IRIS
DALLIO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.102
AS - Asia 1.781
NA - Nord America 1.589
SA - Sud America 281
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 35
OC - Oceania 8
Totale 7.933
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.099
US - Stati Uniti d'America 1.526
SG - Singapore 606
IT - Italia 462
CN - Cina 383
IE - Irlanda 244
VN - Vietnam 233
HK - Hong Kong 231
BR - Brasile 225
KR - Corea 97
DE - Germania 81
JP - Giappone 75
GB - Regno Unito 62
IN - India 53
FR - Francia 35
CA - Canada 30
BD - Bangladesh 28
AR - Argentina 24
NL - Olanda 23
MX - Messico 21
AT - Austria 20
FI - Finlandia 19
ZA - Sudafrica 13
GR - Grecia 12
ID - Indonesia 12
EC - Ecuador 11
IQ - Iraq 11
PK - Pakistan 10
PL - Polonia 9
AU - Australia 8
EG - Egitto 8
ES - Italia 7
TR - Turchia 7
UZ - Uzbekistan 7
CO - Colombia 6
PY - Paraguay 6
UA - Ucraina 6
SE - Svezia 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
MY - Malesia 4
PE - Perù 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
KE - Kenya 3
LK - Sri Lanka 3
MA - Marocco 3
MK - Macedonia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
CR - Costa Rica 1
GP - Guadalupe 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 7.796
Salva come PNG Salva come JPEG
Città #
Moscow 1.138
Singapore 304
San Jose 258
Dublin 242
Hong Kong 226
Santa Clara 175
Naples 132
Ashburn 130
Chandler 108
Seoul 97
Beijing 92
Ho Chi Minh City 90
Hefei 76
New York 60
Council Bluffs 58
Hanoi 56
Dallas 41
Los Angeles 33
Boardman 28
Bengaluru 27
Princeton 26
Roxbury 25
Munich 22
Bremen 21
Cambridge 21
São Paulo 21
The Dalles 18
Da Nang 17
Nuremberg 16
Orem 16
Rome 16
Caserta 14
Amsterdam 13
Aversa 13
Vienna 13
Mexico City 12
Milan 12
Paris 12
Atlanta 10
Boydton 10
Tokyo 10
Montreal 9
Salerno 9
Des Moines 8
Houston 8
Memphis 8
San Francisco 8
Warsaw 8
Belo Horizonte 7
Biên Hòa 7
Chennai 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Helsinki 7
Medford 7
Ninh Bình 7
Tashkent 7
Toronto 7
Turku 7
Baghdad 6
Brasília 6
Brooklyn 6
Castellammare di Stabia 6
Fondi 6
Piscataway 6
Sennori 6
Viterbo 6
Bari 5
Boston 5
Guangzhou 5
Hillsboro 5
Lappeenranta 5
Manchester 5
Mumbai 5
Quito 5
Shanghai 5
Camerino 4
Chengdu 4
Chicago 4
Curitiba 4
Dhaka 4
Groningen 4
Hangzhou 4
Hyderabad 4
Hải Dương 4
Johannesburg 4
London 4
Manassas 4
Manaus 4
Newark 4
Rio de Janeiro 4
Sialkot 4
Tianjin 4
Wilmington 4
Astana 3
Asunción 3
Bauru 3
Bisaccia 3
Brno 3
Totale 4.031
Salva come PNG Salva come JPEG
Nome #
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 201
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 181
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 178
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 162
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 158
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 155
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 148
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 146
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 145
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 143
Light alcohol drinking and the risk of cancer development: a controversial relationship 137
Inflammatory Bowel Diseases: The Role of Gut Microbiota 137
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 137
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 134
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 133
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 131
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 131
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 129
Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications 129
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 128
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain 127
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements 127
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 127
Exploring the Classic and Novel Pathogenetic Insights of Plastic Exposure in the Genesis and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 125
Environmental bisphenol A exposure triggers trained immunity-related pathways in monocytes 125
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 123
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 121
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 120
Extra-Gastric Manifestations of Helicobacter pylori Infection 119
Risk factors for liver decompensation and hcc in hcv-cirrhotic patients after daas: A multicenter prospective study 119
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 117
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 116
Critical review on the use and abuse of alcohol. When the dose makes the difference 115
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 115
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? 114
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece? 113
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review 111
Cirrhosis and frailty assessment in elderly patients: A paradoxical result 110
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis 109
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 109
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 108
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 106
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 106
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 104
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 101
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications 101
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 99
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot? 99
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications 99
Urinary volatile Organic compounds in non-alcoholic fatty liver disease (NAFLD), type two diabetes mellitus (T2DM) and NAFLD-T2DM coexistence 96
Is it time to reconsider the MRP6 role in bile secretion and LPAC genetic signature? 96
The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials 92
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap? 91
Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort 91
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress 90
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis 88
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 86
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 86
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach 80
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm 80
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 80
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 79
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 75
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 73
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 68
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease 67
The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives 28
From “MAFLD” to “MASLD”: Was This Revolution Worth It? A Head-to-Head Comparison of MAFLD and MASLD Criteria in Estimating Liver Disease Progression and Cardiovascular Risk in Real Life 28
Human Albumin-enriched Peritoneal Dialysis: A Novel Approach to Manage Refractory Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease 20
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 19
Synbiotic Supplementation for Chronic Constipation in Patients Under Peritoneal Dialysis: An Italian Multicenter Prospective Study 15
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study 14
Contrast-enhanced ultrasound as a problem-solving tool and irreversible electroporation for a perivascular/peribiliary segment IVs colorectal liver metastasis: a case report 9
Beyond Insulin Resistance: Exploring the Centrality of the Gut–Liver Axis in Mediating Immunometabolic Dysregulation Driving Hepatocellular Carcinoma in MASLD and Diabetes 9
Redefining Liver Transplantation Indications for Hepatic Malignancies in the Era of Precision Transplant Oncology: An Up-to-Date Narrative Review 6
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives 2
Totale 7.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.567
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 9 8 22 35 15 7 3 6 11 31 53
2022/2023520 39 13 14 37 84 31 0 26 245 7 10 14
2023/2024382 23 10 12 22 59 62 13 1 21 35 40 84
2024/20251.016 6 17 20 46 155 106 140 100 117 126 96 87
2025/20265.496 223 355 279 212 466 2.902 260 238 180 144 138 99
2026/2027196 48 148 0 0 0 0 0 0 0 0 0 0
Totale 7.933